Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008509

EVP & Chief R & QA Officer gave up 4,437 shares (to pay taxes)

  • EVP & Chief R & QA Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Clark Mitchall G. EVP & Chief R & QA Officer 2018-02-06 Grant or award +25,000 188,054 D
Clark Mitchall G. EVP & Chief R & QA Officer 2018-02-06 Shares withheld for taxes −4,437 $35.80 $158,845 183,617 D
Derivatives
Clark Mitchall G. EVP & Chief R & QA Officer 2018-02-06 Grant or award · Employee Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X03/doc4.xml…